Page 28 - Mobile Android News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CHICAGO —Adding relatlimab to nivolumab improved PFS, OS and objective response rates across key subgroups of patients with previously untreated metastatic or unresectable melanoma, according to a study presented at ASCO Annual Meeting.The results showed superiority of nivolumab and relatlimab-rmbw (Opdualag, Bristol Myers Squibb) over single-agent nivolumab (Opdivo, Bristol Myers Squibb),

We have long known that our diets affect our health, but many questions remain about diet’s impact on conditions like cancer and its potential value in treating a wide variety of health conditions. Two studies presented recently at Digestive Disease Week 2022 shed further light on these connections. Although they examine two different conditions — irritable bowel syndrome and

The Environmental Working Group reported that about 75% of evaluated products rated poorly for skin protection from the sun and include potentially harmful ingredients, according to a press release.The statistic was released as a part of the Environmental Working Group’s (EWG) 16th annual Guide to Sunscreens, which assessed the effectiveness of more than 1,850 products advertising sun

Peer worker–facilitated psychiatric advance directives proved effective in decreasing compulsory hospital admissions and increasing certain positive outcomes for those with mental illness, according to a study published in JAMA Psychiatry. “In the last 20 years, several randomized clinical trials have assessed the effectiveness of interventions in reducing compulsory psychiatric

SAN DIEGO — Gastroenterology societies should refrain from incorporating race and ethnicity into clinical guidelines as doing so may exacerbate health inequities, according to research presented at Digestive Disease Week 2022. “Race is a social construct, yet health care workers still use race and ethnicity to guide clinical decision-making,” Shazia M. Siddique, MD, MSHP,